<p>India’s <span class="key-term" data-definition="Bioeconomy — Economic activities that use biological resources, processes and principles to produce goods and services, contributing to GDP and employment (GS3: Economy)">Bioeconomy</span> has surged from roughly **$10 bn in 2014** to **$195 bn in 2025**, registering an annual growth of **17‑18 %**. Union Minister of State (Independent Charge) for Science & Technology, <strong>Dr Jitendra Singh</strong>, highlighted this expansion at the 14th Foundation Day of <span class="key-term" data-definition="BIRAC (Biotechnology Industry Research Assistance Council) — A government agency under the Department of Biotechnology that funds and supports biotech innovation and startups (GS3: Economy, GS4: Ethics)">BIRAC</span>, underscoring the sector’s role in healthcare, agriculture, climate mitigation and sustainable manufacturing.</p>
<h3>Key Developments</h3>
<ul>
<li><strong>Target of $300 bn by 2030</strong> – The government aims to reach this milestone through a robust ecosystem of scientists, entrepreneurs and policy support.</li>
<li><strong>BioE3 Policy launch</strong> – The <span class="key-term" data-definition="BioE3 Policy — ‘Biotechnology for Economy, Environment and Employment’ policy aimed at promoting sustainable biomanufacturing, precision therapeutics and climate‑resilient agriculture (GS3: Economy)">BioE3 Policy</span> will boost precision biotherapeutics, smart proteins, climate‑resilient crops, bio‑based chemicals and carbon‑capture technologies.</li>
<li><strong>RDI Fund allocation</strong> – A dedicated <span class="key-term" data-definition="RDI Fund — Research, Development and Innovation fund of ₹1 lakh crore allocated to boost deep‑tech and biotech ventures (GS3: Economy)">RDI Fund</span> of **₹1 lakh crore** places <span class="key-term" data-definition="BIRAC (Biotechnology Industry Research Assistance Council) — A government agency under the Department of Biotechnology that funds and supports biotech innovation and startups (GS3: Economy, GS4: Ethics)">BIRAC</span> at the centre of scaling biotech ventures.</li>
<li><strong>Infrastructure push</strong> – Creation of shared <span class="key-term" data-definition="Bio‑foundries — Shared manufacturing facilities that provide advanced bioprocessing capabilities to multiple firms, reducing capital costs (GS3: Economy)">bio‑foundries</span>, <span class="key-term" data-definition="Bio‑foundries — Shared manufacturing facilities that provide advanced bioprocessing capabilities to multiple firms, reducing capital costs (GS3: Economy)">Bio‑AI hubs</span> and advanced biomanufacturing platforms.</li>
<li><strong>Startup ecosystem</strong> – Over **11,800 biotech startups** are now active, driving innovation and job creation.</li>
</ul>
<h3>Important Facts</h3>
<ul>
<li>The <span class="key-term" data-definition="India Bioeconomy Report (IBER) — Periodic report that quantifies the size, growth and contribution of the bioeconomy to India’s GDP (GS3: Economy)">India Bioeconomy Report (IBER) 2026</span> records a **CAGR of ~18 %** since 2020.</li>
<li>The sector contributes **4.8 % of national GDP** (≈$195.3 bn) and has more than **doubled in size** since 2020.</li>
<li>Key focus areas under BioE3 include <em>precision biotherapeutics, smart proteins, climate‑resilient agriculture, bio‑based chemicals and carbon capture.</em></li>
<li>Government funding and mentorship have led to commercialization of affordable healthcare solutions and sustainable technologies.</li>
</ul>
<h3>UPSC Relevance</h3>
<p>The rapid expansion of the <span class="key-term" data-definition="Bioeconomy — Economic activities that use biological resources, processes and principles to produce goods and services, contributing to GDP and employment (GS3: Economy)">Bioeconomy</span> touches multiple GS papers. For GS‑III (Economy) it illustrates a high‑growth sector contributing to GDP, employment and export potential. For GS‑II (Polity) the role of ministries, <span class="key-term" data-definition="BIRAC (Biotechnology Industry Research Assistance Council) — A government agency under the Department of Biotechnology that funds and supports biotech innovation and startups (GS3: Economy, GS4: Ethics)">BIRAC</span> and policy instruments like the <span class="key-term" data-definition="BioE3 Policy — ‘Biotechnology for Economy, Environment and Employment’ policy aimed at promoting sustainable biomanufacturing, precision therapeutics and climate‑resilient agriculture (GS3: Economy)">BioE3 Policy</span> demonstrate governance for innovation. For GS‑IV (Ethics) the emphasis on inclusive talent development, especially from tier‑2/3 cities and women entrepreneurs, aligns with equitable growth objectives.</p>
<h3>Way Forward</h3>
<ul>
<li>Strengthen public‑private partnerships to accelerate scale‑up of promising biotech products.</li>
<li>Expand shared infrastructure like <span class="key-term" data-definition="Bio‑foundries — Shared manufacturing facilities that provide advanced bioprocessing capabilities to multiple firms, reducing capital costs (GS3: Economy)">bio‑foundries</span> across regions to reduce geographic disparity.</li>
<li>Enhance skill development programmes targeting youth in tier‑2/3 cities to sustain the talent pipeline.</li>
<li>Monitor and evaluate the impact of the <span class="key-term" data-definition="RDI Fund — Research, Development and Innovation fund of ₹1 lakh crore allocated to boost deep‑tech and biotech ventures (GS3: Economy)">RDI Fund</span> to ensure efficient capital deployment.</li>
<li>Promote export‑oriented biotech clusters to improve trade balance and global competitiveness.</li>
</ul>
<p>Collectively, these measures aim to cement India’s position as a leading global biotech hub and achieve the **$300 bn bioeconomy target by 2030**, thereby supporting the nation’s self‑reliant development agenda.</p>
Loading page, please wait…